Genta-Equine
Active substance
ATC code
Species
Horses (non food producing horses).
Indications
For the treatment of infections of the lower respiratory tract in horses caused by aerobic Gramnegative bacteria susceptible to gentamicin.
Dose to be administered and administration route
Horses:
Intravenous use.
Single dose of 6.6 mg/kg body weight given intravenously once daily for 3–5 consecutive days.
To ensure a correct dosage, bodyweight should be determined as accurately as possible to avoid under- or over-dosing. The dosing regimen must not be exceeded.
The use of gentamicin in foals and neonates is not recommended.
Adverse reactions
Hypersensitivity reactions have been reported very rarely following the use Genta- Equine 100 mg/ml Solution for Injection for Horses.
A local reaction may occur at the injection site, especially in case of repeated injections in adjacent sites. See Section 4.5 Part A.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
References
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | |
| EAN | 7046265529132 |
